Hospitals & Clinics
-
Opportunity India Desk Mar 22, 2018 - 1 min readSun Pharma has received a US Food and Drug Administration approval for its novel psoriasis drug TildraKizumab, the first new drug approval for India’s largest drug maker. The drug, which will be sold under brand name Ilumya, is expected to treat adults with moderate-to-severe plaque psoriasis, an auto immune disease. Illumya ...
-
Opportunity India Desk Mar 19, 2018 - 1 min readDrug major Lupin has received approval from the US health regulator to market Desoximetasone Topical spray, a formulation for treatment of plaque psoriasis, in the American market. It is a generic version of Taro Pharmaceuticals USA Inc.'s Topicort Topical Spray, 0.25%. The approval has been granted to the product ...
-
Opportunity India Desk Mar 17, 2018 - 2 min readIndia’s apex drug regulator is considering action like cancelling the licences and even legal action several pharmaceutical firms, including listed firms like Wockhardt for making and marketing certain combination medicines to treat ailments like fungal infections and diabetes without its approval. Reportedly drug makers have not proven their safety and effectiveness ...
-
Opportunity India Desk Mar 17, 2018 - 1 min readDrug major Dr Reddy's Laboratories has claimed to have received four observations from US health regulator after inspecting its active pharmaceutical ingredients (API) facility in Telangana. Dr Reddy's in a regulatory filing said, "The audit of our API Hyderabad plant 1 at Jinnaram Mandal, Medak district, Telangana, by the USFDA has ...
-
Opportunity India Desk Mar 16, 2018 - 2 min readThe health insurance arm of Aditya Birla Capital Limited, Aditya Birla Health Insurance Co. Limited. (ABHICL) has recently launched 'Activ Assure'- a health insurance product, key offering from its 'Protection' portfolio. 'Activ Assure' is a health insurance offering incorporating ABHICL's unique HealthReturnsTM program that incentivizes customers upto 30% of their premium ...
-
Opportunity India Desk Mar 14, 2018 - 1 min readWith the rising health consciousness among the people and incidents of food borne diseses, food start-up AwesomeChef is eyeing huge potential for its do-it-yourself (DIY) Nutribowl health meal kits. The meal kits contain unprocessed food, rice or wheat along with the fresh ingredients measured for one person along with the recipe. ...
-
Opportunity India Desk Mar 01, 2018 - 1 min readDrug firm Zydus Cadila has confirmed to have received the final approval from US health regulator FDA to market Dexmedetomidine Hydrochloride injection used for sedation of patients under intensive care. Zydus Cadila in a regulatory filing said the approval from USFDA is to market Dexmedetomidine Hydrochloride injection 200 mcg (base)/ 2 ...
-
Opportunity India Desk Feb 28, 2018 - 2 min readGiving a fillip to the Government’s ‘Make in India’ initiative, Axiostat has become the first Indian wound care product to receive 510(K) FDA clearance in the US for its pioneering haemostatic dressing. Axiostat, a 100% chitosan haemostatic dressing to stop external bleeding, was earlier approved with CE mark in Europe. The FDA clearance ...
-
Opportunity India Desk Feb 27, 2018 - 2 min readSanofi Group owned Pharmacy Shantha Biotechnics, has confirmed the approval from the World Health Organisation (WHO) for its oral cholera vaccine Shanchol which eliminates the challenges of maintaining the vaccine cold chain between +2°C and +8°C to maintain vaccine potency during transport. According to the company, Shanchol™ cholera vaccine is the ...
-
Opportunity India Desk Feb 26, 2018 - 1 min readScientists have been successful to grow mini tumours in a lab that will be used to test various drugs invented for cancer in order to find the best treatment. According to a study published in Journal Science, scientists treated the tumours with a dozen drugs. As a result, they found that ...